Carrie B Hruska1. 1. 1 Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55955.
Abstract
OBJECTIVE: The purposes of this review are to discuss the motivation for supplemental screening, to address molecular breast imaging (MBI) radiation dose concerns, and to provide an updated guide to current MBI technology, clinical protocols, and screening performance. Future directions of MBI are also discussed. CONCLUSION: MBI offers detection of mammographically occult cancers in women with dense breasts. Although MBI has been under investigation for nearly 15 years, it has yet to gain widespread adoption in breast screening.
OBJECTIVE: The purposes of this review are to discuss the motivation for supplemental screening, to address molecular breast imaging (MBI) radiation dose concerns, and to provide an updated guide to current MBI technology, clinical protocols, and screening performance. Future directions of MBI are also discussed. CONCLUSION: MBI offers detection of mammographically occult cancers in women with dense breasts. Although MBI has been under investigation for nearly 15 years, it has yet to gain widespread adoption in breast screening.
Entities:
Keywords:
breast density; breast screening; molecular breast imaging; radiation risk
Authors: Rickey E Carter; Zachi I Attia; Jennifer R Geske; Amy Lynn Conners; Dana H Whaley; Katie N Hunt; Michael K O'Connor; Deborah J Rhodes; Carrie B Hruska Journal: JCO Clin Cancer Inform Date: 2019-02
Authors: Matthew F Covington; Ephraim E Parent; Elizabeth H Dibble; Gaiane M Rauch; Amy M Fowler Journal: J Nucl Med Date: 2021-12-09 Impact factor: 11.082
Authors: Wendie A Berg; Elizabeth A Rafferty; Sarah M Friedewald; Carrie B Hruska; Habib Rahbar Journal: AJR Am J Roentgenol Date: 2020-12-23 Impact factor: 3.959